Last update 27 Feb 2026

EP-0226

Overview

Basic Info

Drug Type
Chemical drugs
Synonyms
EP-0226
Target
Cav2.2
Action
modulators
Mechanism
Cav2.2 modulators(Voltage-gated N-type calcium channel alpha-1B subunit modulators)
Therapeutic Areas
Nervous System DiseasesOther Diseases
Active Indication
Neuralgia
Inactive Indication-
Originator Organization
Chengdu Easton Biopharmaceuticals Co., Ltd.Chengdu Easton Biopharmaceuticals Co., Ltd.
Active Organization
Zhong Ke Zhong Shan Yao Wu Chuang Xin Yan Jiu YuanShanghai Institute of Materia Medica Chinese Academy of SciShanghai Institute of Materia Medica Chinese Academy of SciChengdu Easton Biopharmaceuticals Co., Ltd.Chengdu Easton Biopharmaceuticals Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with EP-0226
CTR20260150
/ RecruitingPhase 1
评价EP-0226片在中国健康受试者中单次和多次给药的单中心、随机、双盲、安慰剂对照、剂量递增的安全性、耐受性和药代动力学研究
[Translation] A single-center, randomized, double-blind, placebo-controlled, dose-escalation safety, tolerability, and pharmacokinetic study evaluating EP-0226 tablets in healthy Chinese subjects for single and multiple doses.
100 Clinical Results associated with EP-0226
Login to view more data
100 Translational Medicine associated with EP-0226
Login to view more data
100 Patents (Medical) associated with EP-0226
Login to view more data
100 Deals associated with EP-0226
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
NeuralgiaPhase 1
China
Zhong Ke Zhong Shan Yao Wu Chuang Xin Yan Jiu Yuan
20 Jan 2026
NeuralgiaPhase 1
China
Chengdu Easton Biopharmaceuticals Co., Ltd.Chengdu Easton Biopharmaceuticals Co., Ltd.
20 Jan 2026
NeuralgiaPhase 1
China
Shanghai Institute of Materia Medica Chinese Academy of SciShanghai Institute of Materia Medica Chinese Academy of Sci
20 Jan 2026
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free